Cleared Special

K223842 - DRX - Compass (FDA 510(k) Clearance)

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K223842 · Carestream Health, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2023
Decision
29d
Days
Class 2
Risk

K223842 is an FDA 510(k) clearance for the DRX - Compass. Classified as System, X-ray, Stationary (product code KPR), Class II - Special Controls.

Submitted by Carestream Health, Inc. (China (Shanghai) Pilot Free Trade Zone, CN). The FDA issued a Cleared decision on January 20, 2023 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Carestream Health, Inc. devices

Submission Details

510(k) Number K223842 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 2022
Decision Date January 20, 2023
Days to Decision 29 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d faster than avg
Panel avg: 107d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code KPR System, X-ray, Stationary
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KPR System, X-ray, Stationary

All 354
Devices cleared under the same product code (KPR) and FDA review panel - the closest regulatory comparables to K223842.
AeroDR TX c02
K253446 · Dk Medical Systems Co., Ltd. · Apr 2026
DRX-Evolution Plus X-ray System, DRX-Compass Mobile X-ray System, Lux HD 35 detector, Lux HD 43 detector
K250954 · Carestream Health · Jan 2026
uDR Arria & uDR Aris
K252000 · Shanghai United Imaging Healthcare Co., Ltd. · Nov 2025
uDR Aurora CX
K251167 · Shanghai United Imaging Healthcare Co., Ltd. · Sep 2025
Definium Tempo Select
K250788 · Ge Hualun Medical Systems Co. , Ltd. · Aug 2025
INNOVISION-DXII
K250790 · Dk Medical Systems Co., Ltd. · Aug 2025